Veracyte (VCYT) EBIT Growth (1y) (2013 - 2026)
Veracyte (VCYT) EBIT Growth (1y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 30,529.42 Bn | 30,528.96 Bn | 1.11 Bn | -130.92% |
| 2 | Thermo Fisher Scientific | 183.75 Bn | 180.50 Bn | 7.74 Bn | 8.57% |
| 3 | Danaher | 133.13 Bn | 127.43 Bn | 3.59 Bn | 5.49% |
| 4 | Idexx Laboratories | 46.14 Bn | 45.94 Bn | 722.74 Mn | 14.55% |
| 5 | Agilent Technologies | 38.20 Bn | 36.39 Bn | 990.00 Mn | 33.00% |
| 6 | Natera | 31.50 Bn | 30.40 Bn | 696.04 Mn | -18.11% |
| 7 | Iqvia Holdings | 31.34 Bn | 29.36 Bn | 1.36 Bn | 3.63% |
| 8 | Illumina | 24.51 Bn | 23.36 Bn | 721.00 Mn | 27.44% |
| 9 | Mettler Toledo International | 23.53 Bn | 23.47 Bn | 555.82 Mn | 2.57% |
| 10 | Veracyte | 3.91 Bn | 3.65 Bn | 101.16 Mn | 679.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 679.82% |
| Dec 31, 2025 | 790.90% |
| Sep 30, 2025 | 90.95% |
| Jun 30, 2025 | -214.37% |
| Mar 31, 2025 | 162.37% |
| Dec 31, 2024 | 111.76% |
| Sep 30, 2024 | 137.86% |
| Jun 30, 2024 | 157.21% |
| Mar 31, 2024 | 55.65% |
| Dec 31, 2023 | -555.11% |
| Sep 30, 2023 | -227.88% |
| Jun 30, 2023 | 24.99% |
| Mar 31, 2023 | 31.15% |
| Dec 31, 2022 | 56.05% |
| Sep 30, 2022 | 41.97% |
| Jun 30, 2022 | -43.60% |
| Mar 31, 2022 | 66.43% |
| Dec 31, 2021 | -52.79% |
| Sep 30, 2021 | -310.26% |
| Jun 30, 2021 | 32.37% |